Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Piyarat Limpawittayakul"'
Autor:
Chayanee Samdaengpan, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Jomtana Siripaibun, Chumut Phanthunane, Walaipan Tantiyavarong, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Kamonwan Soonklang, Thitapha Thongchai, Piyarat Limpawittayakul
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSECorticosteroids are known to diminish immune response ability, which is generally used in routine premedication for chemotherapy. The intersecting of timeframe between the corticosteroid's duration of action and peak COVID-19 vaccine efficacy
Externí odkaz:
https://doaj.org/article/ac53c804631247bb8a521d352dd775cb
Publikováno v:
Respiratory Medicine Case Reports, Vol 48, Iss , Pp 102004- (2024)
Background: Paclitaxel is a chemotherapeutic drug widely used in breast cancer treatment. While common side effects are possible, paclitaxel-induced pneumonitis is rare, with an estimated incidence of 1%–5% and a high mortality rate. Case presentat
Externí odkaz:
https://doaj.org/article/247142a5a4c543a182f856f6d83dcb1e
Autor:
Walaipan Tantiyavarong, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Piyarat Limpawittayakul, Bowon Weerasubpong, Jomtana Siripaibun, Chumut Phanthunane, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Pichaya Tantiyavarong, Chayanee Samdaengpan
Publikováno v:
JCO Global Oncology, Vol , Iss 9 (2023)
PURPOSEThe COVID-19 pandemic has affected public health worldwide. The efficacy and safety of COVID-19 vaccines have been evaluated in the general population; however, data on patients with malignancies are limited.METHODSThis prospective longitudina
Externí odkaz:
https://doaj.org/article/341cddea03c0451fac5d2273ae472247
Autor:
Piyarat Limpawittayakul, Prakongboon Sungkasubun, Worawit Chaiwiriyawong, Archara Supavavej, Bowon Weerasubpong, Jomtana Siripaibun, Chumut Phanthunane, Wisut Lamlertthon, Teerapat Ungtrakul, Kriangkrai Tawinprai, Walaipan Tantiyavarong, Chayanee Samdaengpan
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 6 (2022)
Introduction Cancer patients are more vulnerable to coronavirus disease 2019 (COVID-19) owing to their compromised immune status. However, data regarding COVID-19 vaccine safety and immune response in cancer patients are scarce. Method This prospecti
Externí odkaz:
https://doaj.org/article/2f0ade7bb3d7436da35900842d62e101